ABH Healthcare (NSE:ABH) 5-Year EBITDA Growth Rate: 0.00% (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ABH ABH Healthcare Ltd NSE:ABH
15 GF Score
Price ₹43.75
! 2 Warning Signs
View Full Analysis

What is ABH Healthcare 5-Year EBITDA Growth Rate?

ABH Healthcare NSE:ABH +9.92% 15 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2025. GuruFocus rates NSE:ABH with a GF Score™ of 15/100. The stock has 2 warning signs investors should review.

ABH Healthcare's EBITDA per Share for the three months ended in Mar. 2025 was ₹.

During the past 12 months, ABH Healthcare's average EBITDA Per Share Growth Rate was 8.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 53.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 4 years, the highest 3-Year average EBITDA Per Share Growth Rate of ABH Healthcare was 293.30% per year. The lowest was 53.00% per year. And the median was 173.15% per year.

ABH Healthcare  (NSE:ABH) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

ABH Healthcare 5-Year EBITDA Growth Rate Related Terms

NSE:ABH vs : 5-Year EBITDA Growth Rate Comparison

For the Medical Care Facilities subindustry, ABH Healthcare's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ABH Healthcare 5-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABH Healthcare's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where ABH Healthcare's 5-Year EBITDA Growth Rate falls into.


NSE:ABH
15GF Score
ABH Healthcare Ltd NSE:ABH
5-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ABH Healthcare 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 5-Year EBITDA Growth Rate of 0.00% mean?
ABH Healthcare (NSE:ABH) has a 5-Year EBITDA Growth Rate of 0.00% as of Mar. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for ABH Healthcare and its competitors.
Is ABH Healthcare's 5-Year EBITDA Growth Rate too high?
ABH Healthcare's current 5-Year EBITDA Growth Rate is 0.00%. Overall, ABH Healthcare has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does ABH Healthcare's 5-Year EBITDA Growth Rate compare to ?
ABH Healthcare's 5-Year EBITDA Growth Rate of 0.00% can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
A good 5-Year EBITDA Growth Rate depends on the Healthcare Providers & Services industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for ABH Healthcare and its competitors. ABH Healthcare's current 5-Year EBITDA Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ABH Healthcare stock overvalued right now?
ABH Healthcare (NSE:ABH) has a current 5-Year EBITDA Growth Rate of 0.00%. The current 5-Year EBITDA Growth Rate is 0.00%. ABH Healthcare's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For ABH Healthcare (NSE:ABH), the current 5-Year EBITDA Growth Rate is 0.00% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ABH Healthcare Business Description

Comparable Companies
Address Martyr Anil Baghi Road, Anil Baghi Hospital, Ferozepur, PB, IND, 152002
ABH Healthcare Ltd is engaged in the business of establishing, maintaining, and assisting healthcare services in India, in the form of Super Speciality Hospitals and allied services such as Laboratories & Diagnostic Centres, Blood Bank and other related services. Its medical services cover specialties such as cardiology, neurology, gastroenterology, urology, pulmonology, nephrology, obstetrics and gynecology, critical care, orthopedics, general and laparoscopic surgery, dentistry, physiotherapy, dermatology, and radiology. The company derives the majority of inpatient revenue from its internal medicine, cardiology, neurosurgery, and orthopedics / joint replacement/trauma services.
15GF Score

Get the complete analysis for NSE:ABH

5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹43.75
Price